Literature DB >> 9833096

Graded exchange reaming and nailing of non-unions. Strength and mineralisation in rat femoral bone.

S E Utvåg1, O Grundnes, O Reikerås.   

Abstract

The effect of graded exchange reaming and intramedullary nailing on a non-union model in the rat femur was studied by clinical, radiological, bone mineralisation and biomechanical methods. A standardised procedure was first developed to create a non-union that did not heal and in which non-union developed consistently. In 30 male Wistar rats a standardised osteotomy was produced in the left femur diaphysis. The fractures were reamed to 1.5 mm and nailed with a soft polyethylene nail for 12 weeks. After 1 week the fractures were manipulated in bending and rotation every 2nd day for 5 weeks. At 12 weeks radiographs demonstrated a hypertrophic non-union in all fractures, and the rats were randomly divided into three groups. In the control group no reoperation was performed (group C). In group 1.6 exchange reaming to 1.6 mm and medullary nailing were performed, and reaming and nailing to 2.0 mm in group 2.0. The effect of extensive versus modest reaming and nailing on bone repair was then assessed 12 weeks later. Physical examination, radiographs, bone mineralisation measurements by dual energy X-ray absorptiometry (DEXA) and biomechanical femurs evaluated by a three-point bending test in a Mini Bionix (MTS) testing system were employed. In the control group radiographs revealed a state of non-union in all fractures, and the mechanical strength was significantly reduced compared with both intervention groups. Bone mineral content (BMC) and bone mineral density (BMD) were reduced in the callus region compared with group 2.0. In the intervention groups radiographs showed various degrees of union. Mechanical testing showed that the fracture energy was significantly higher in group 2.0 than in group 1.6. The finding that extensive exchange reaming and nailing seems favourable in non-unions of diaphyseal fractures compared with modest reaming may have clinical implications.

Entities:  

Mesh:

Year:  1998        PMID: 9833096     DOI: 10.1007/s004020050300

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  6 in total

1.  Limb lengthening and then insertion of an intramedullary nail: a case-matched comparison.

Authors:  S Robert Rozbruch; Dawn Kleinman; Austin T Fragomen; Svetlana Ilizarov
Journal:  Clin Orthop Relat Res       Date:  2008-09-18       Impact factor: 4.176

2.  Exchange reamed nailing compared to augmentation compression plating leaving the inserted nail in situ in the treatment of aseptic tibial non-union: a two-centre study.

Authors:  Atesch Ateschrang; Georgios Karavalakis; Christoph Gonser; Ulrich Liener; Thomas Freude; Ulrich Stöckle; Matthias Walcher; Derek Zieker
Journal:  Wien Klin Wochenschr       Date:  2013-05-15       Impact factor: 1.704

3.  Reamed Intramedullary Nailing has an Adverse Effect on Bone Regeneration During the Distraction Phase in Tibial Lengthening.

Authors:  Keun Jung Ryu; Bang Hyun Kim; Jin Ho Hwang; Hyun Woo Kim; Dong Hoon Lee
Journal:  Clin Orthop Relat Res       Date:  2015-10-27       Impact factor: 4.176

4.  A 3D-printed, personalized, biomechanics-specific beta-tricalcium phosphate bioceramic rod system: personalized treatment strategy for patients with femoral shaft non-union based on finite element analysis.

Authors:  Jian Lu; Qi-Yang Wang; Jia-Gen Sheng; Shang-Chun Guo; Shi-Cong Tao
Journal:  BMC Musculoskelet Disord       Date:  2020-07-01       Impact factor: 2.362

Review 5.  Lengthening Nails for Distraction Osteogenesis: A Review of Current Practice and Presentation of Extended Indications.

Authors:  Ahmed H Barakat; Junaid Sayani; Christopher O'Dowd-Booth; Enis Guryel
Journal:  Strategies Trauma Limb Reconstr       Date:  2020 Jan-Apr

6.  Development of a tibial experimental non-union model in rats.

Authors:  Xue-Qiang Wu; Dong Wang; Yang Liu; Jun-Lin Zhou
Journal:  J Orthop Surg Res       Date:  2021-04-14       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.